Dennis M. Lanfear

Denny Lanfear founded Coherus in 2010 and is President and Chief Executive Officer. Denny is a biopharmaceutical leader with a proven track record of entrepreneurial success and achievement. In 2010, after decades working in the biopharmaceutical industry, he founded Coherus BioSciences with the vision of improving the public’s access to high-quality, life-changing medicines. Under Mr. Lanfear’s leadership as President, CEO, and Chairman, Coherus BioSciences was transformed into the industry’s leading pure play biosimilar company. A dedicated entrepreneur, Mr. Lanfear founded two other companies before Coherus BioSciences: Saronyx, Inc., a drug development software services company and the biopharmaceutical company InteKrin Therapeutics. He served as CEO of both firms. Mr. Lanfear held various senior leadership roles at Amgen Inc., serving as Vice President of Process Development before transitioning to the Commercial side of the business as Vice President of Market Development. The Process Development department was initiated and became a key strategic advantage for the company under his leadership. During his 13-year tenure at Amgen he also acquired substantial operations experience and was tasked with integrating more than 2,500 operations and staff worldwide after the company’s explosive growth. Mr. Lanfear’s product development experience includes various leadership positions with multiple product development programs including growth factors, somatotrophins, and neurotrophins, having directed efforts from preclinical studies to Phase 3 clinical trials. Mr. Lanfear currently serves on the board of directors of NEUVOGEN, Inc. Mr. Lanfear holds B.S. degrees in Chemical Engineering and Biochemistry from Michigan State University and a M.B.A. from the Anderson School of Management at the University of California, Los Angeles.